Packaging Packs a Problem for Medtronic

Following struggles with resin and tray packaging constraints, Medtronic has reported that supply chain challenges are beginning to recover.
CEO Geoff Martha said “This quarter was a big quarter for us. We made quite a bit of progress on some of the supply chain concerns that we had, in some cases specific issues we had to resolve, and building our manufacturing capacity as well.”
To guarantee that the firm will be given urgency given, Medtronic has moved 100 of its workers to the same location as its major suppliers Additionally, it has started negotiating contracts with raw material suppliers instead of their previous approach, going via intermediaries, which slowed the supply and distribution process.
“We’re not totally out of the woods yet, but our back-orders are coming down.”
The Covid 19 lockdown employed by China had detrimental effects on the medical surgical sector, with vast amounts of equipment and material imported. This caused a significant drop in sales revenue for respiratory, renal, gastrointestinal and surgical innovations sectors.
The FDA issued Medtronic a cautionary letter regarding issues with the MiniMed 600 series insulin pump devices. This is currently being dealt with by the firms diabetes division, with Geoff Martha proclaiming they have finished over 90% of the mandatory corrective steps.
Head of the diabetes unit, Que Dallara, explained that their “short-term focus is remediating the warning letter and also making progress with the FDA around approval of the 780G and Guardian 4 sensor system. We continue to be encouraged by that, making good progress, and so our hope is that we can remediate that and secure approval in the near term.”